Greenbrook Tms (GBNHF) has released an update.
Neuronetics, Inc. and Greenbrook TMS Inc. are set to merge in an all-stock deal poised to revolutionize the U.S. mental health space by combining their strengths in patient care and innovative treatments. The merger aims to increase patient access to the advanced NeuroStar therapy, enhance provider education, and drive a more robust financial profile with potential long-term shareholder value.
For further insights into GBNHF stock, check out TipRanks’ Stock Analysis page.
